How to Buy Zevra Therapeutics Stock
Zevra Therapeutics Inc
Zevra Therapeutics, Inc. , founded in 2006 and based in Celebration, Florida, is a biopharmaceutical company dedicated to discovering and developing innovative treatments for rare diseases.
Zevra Therapeutics stock last closed at $9.51, down 1.35% from the previous day, and has decreased 14.4% in one year. It has underperformed other stocks in the Biotechnology industry by 0.01 percentage points. Zevra Therapeutics stock is currently +32.82% from its 52-week low of $7.16, and -36.75% from its 52-week high of $15.04.
At the moment, there are 59.12M ZVRA shares outstanding. The market capitalization of ZVRA is $562.18M. In the past 24 hours, 944,000 ZVRA shares were traded.
How to Buy Zevra Therapeutics Stock
Wondering how to invest in Zevra Therapeutics stock? Here's how.
- Choose where to buy Zevra Therapeutics stock: You need to pick a stock brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you figure out where to buy Zevra Therapeutics stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Put funds into your brokerage account: Choose your payment method and add your info.
- Analyze Zevra Therapeutics stock: The Zevra Therapeutics ticker symbol is ZVRA. Is Zevra Therapeutics stock a good investment? Should you buy shares of ZVRA? How do ZVRA's underlying business fundamentals look? Do top analysts think Zevra Therapeutics is a good buy? Why has ZVRA's stock price moved recently? (Hint: Our stock market research website can help you evaluate if ZVRA is a good stock to buy).
- Place your ZVRA trade: Decide if you will purchase ZVRA shares at the current market price or use a limit order to purchase ZVRA stock at a given price.
- Monitor your investment in ZVRA: Create a watchlist to key updates about your investment in Zevra Therapeutics stock.
Step 1: Choose where to buy Zevra Therapeutics stock
You need an online brokerage account in order to access the NASDAQ market and buy ZVRA shares.
Our preferred brokerage: eToro
In our opinion, eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global financial markets: From Technology to Energy, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen the best brokerage, it's time to fill out some personal info so you are able to invest in ZVRA stock today.
How to Start a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to start a new brokerage account.
- Send your application by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've finished signing up on stock apps to use, your next step is to transfer the money for your investment:
Watch the video below if you need help transferring funds into your new brokerage account.
Step 4: Analyze Zevra Therapeutics stock
Once you have identified the best place to buy Zevra Therapeutics stock, it's important to evaluate their stock before you invest, so you truly understand the risk as well as the upside.
Zevra Therapeutics stock quick numbers
ZVRA Fundamentals
WallStreetZen was built to help part-time investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on ZVRA's stock page.
Is ZVRA stock properly valued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge ZVRA's fair value.
Using relative valuations methods:
- ZVRA may be undervalued based on its P/E ratio of 4.64x, relative to Biotechnology industry P/E ratio of 20.12x
- ZVRA may be undervalued based on its P/B ratio of 2.73x, relative to Biotechnology industry P/B ratio of 5.24x
You can access additional valuation research on ZVRA's stock here.
ZVRA Financial Overview
Positive Health Checks:
- ZVRA profit margin has gone up from -226.6% to 101.6% in the past year.
- There are more short-term assets than short-term liabilities on the ZVRA balance sheet.
- ZVRA's operating cash flow of $12.77M allows it to safely service it's debt of $1.15M.
- There are more short-term assets than long-term liabilities on the ZVRA balance sheet.
- ZVRA earnings of $141.12M is not enough to cover its interest payments.
- ZVRA has a low debt to equity ratio of 0.35.
Negative Health Checks:
- Total ZVRA debt is higher than 5 years ago, relative to shareholder equity.
Is it a good time to buy Zevra Therapeutics stock, according to analysts?
Out of 7 Equities analysts who research ZVRA, the consensus analyst rating on Zevra Therapeutics is a Strong Buy
Please note that analyst forecasts are not stock recommendations, nor are they investment advice.
Latest ZVRA Analyst Upgrades/Downgrades
Jason Butler, a top 2% analyst from Citizens maintains ZVRA with a buy rating and raises their ZVRA price target from $18.00 to $25.00, on Jun 9, 2026.
Kristen Kluska, a top 3% analyst from Cantor Fitzgerald maintains ZVRA with a strong buy rating and raises their ZVRA price target from $24.00 to $34.00, on Jun 8, 2026.
Cantor Fitzgerald's Kristen Kluska raised their price target on Zevra Therapeutics (NASDAQ: ZVRA) by 41.7% from $24 to $34 on 2026/06/08. The analyst maintained their Strong Buy rating on the stock.
Kluska attributed their price target hike to Zevra Therapeutics announcing "a new patent to the U.S. FDA for listing in the Orange Book for Miplyffa for Niemann-Pick disease type C."
The analyst explained that the patent expires on 2041/11/19, dictating when generic competitors can legally enter the market.
Kluska added that the patent and its expiry date have a "significantly positive impact" on their discounted cash flow analysis on Zevra Therapeutics.
You can dig deeper into what analysts are forecasting on the Zevra Therapeutics stock forecast page.
ZVRA Trading Indicators
How is ZVRA performing as a company?
Last year, ZVRA revenue was $122.29M. In the past 5 year, ZVRA's revenue has increased by 39.3% per year. This was faster than the Biotechnology industry average of 33.95%.
Learn more about ZVRA's earnings and revenue performance here.
What are ZVRA insiders up to?
Over the past 12 months, insiders at ZVRA have sold more shares than they have bought.
Rahsaan Thompson, Chief Legal Compliance of ZVRA, was the latest ZVRA insider to sell. They sold $438,320.99 worth of ZVRA stock on Jun 22, 2026.
Research more about who owns ZVRA shares here.
Does ZVRA provide a stable income stream?
No, Zevra Therapeutics doesn't provide an income stream by paying out dividends.
What do other traders have to say about ZVRA?
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Place your ZVRA trade
There are two primary options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly fine. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a given dollar amount limit, place a limit order.
Hit the Open button and your broker will place your order.
If you require additional assistance buying stocks on eToro, watch the how to video below:
Step 6: Monitor your investment in ZVRA
Now that you own some ZVRA shares, you'll want to keep up with your company.
Make a watchlist to get the latest updates about your ZVRA stock.
ZVRA Feed
How to Buy Stock in Zevra Therapeutics
To reiterate, here are the 6 steps to buy stock in Zevra Therapeutics:
- Choose where to buy Zevra Therapeutics stock
- Create a brokerage account
- Put funds into your brokerage account
- Analyze Zevra Therapeutics stock
- Place your ZVRA trade
- Monitor your investment in ZVRA
If you are looking for a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to track your new investment in Zevra Therapeutics, add ZVRA to your watchlist below.
More Stock Buying Guides You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.